|
BE567431A
(enExample)
|
1957-05-07 |
|
|
|
|
US4323581A
(en)
|
1978-07-31 |
1982-04-06 |
Johnson & Johnson |
Method of treating carcinogenesis
|
|
IE52670B1
(en)
|
1981-03-03 |
1988-01-20 |
Leo Ab |
Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US4806352A
(en)
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
EP0273512B1
(en)
|
1986-12-19 |
1991-02-27 |
Duphar International Research B.V |
Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
|
|
DE3752123T2
(de)
|
1987-03-09 |
1998-05-14 |
Kyowa Hakko Kogyo Kk |
Derivate des physiologisch aktiven mittels k-252
|
|
ES2052685T3
(es)
|
1987-03-17 |
1994-07-16 |
Akzo Nv |
Metodo para producir un adyuvante libre.
|
|
WO1989007105A1
(fr)
|
1988-02-04 |
1989-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de staurosporine
|
|
CZ280738B6
(cs)
|
1988-02-10 |
1996-04-17 |
F. Hoffmann - La Roche And Co., Aktiengesellschaft |
Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
CA2011896C
(en)
|
1989-04-21 |
2001-05-08 |
Mark Werner |
Ringworm vaccine
|
|
DK0474727T3
(da)
|
1989-05-19 |
1998-01-12 |
Genentech Inc |
HER2 ekstracellulært domæne
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
AU645760B2
(en)
|
1989-08-04 |
1994-01-27 |
Berlex Laboratories, Inc. |
C-erbb-2 external domain: GP75
|
|
US5439936A
(en)
|
1989-10-03 |
1995-08-08 |
The Regents Of The University Of California |
Method of treating certain tumors using illudin analogs
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
EP0471177B1
(en)
|
1990-08-13 |
1995-10-04 |
American Cyanamid Company |
Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
US5284652A
(en)
|
1990-10-26 |
1994-02-08 |
Pier Allan C |
Dermatophyte vaccine
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
AU2866992A
(en)
|
1991-10-10 |
1993-05-03 |
Schering Corporation |
4'-(n-substituted-n-oxide)staurosporine derivatives
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
AU3064992A
(en)
|
1991-11-08 |
1993-06-07 |
University Of Southern California |
Compositions containing k-252 compounds for potentiation of neurotrophin activity
|
|
CA2117303C
(en)
|
1991-11-29 |
2000-10-17 |
Sunil Chada |
Anti-cancer immunotherapeutic vector constructs
|
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
WO1993018150A1
(en)
|
1992-03-02 |
1993-09-16 |
Biocine S.P.A. |
Helicobacter pylori proteins useful for vaccines and diagnostics
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5756494A
(en)
|
1992-07-24 |
1998-05-26 |
Cephalon, Inc. |
Protein kinase inhibitors for treatment of neurological disorders
|
|
US5621100A
(en)
|
1992-07-24 |
1997-04-15 |
Cephalon, Inc. |
K-252a derivatives for treatment of neurological disorders
|
|
DE69331228D1
(en)
|
1992-09-21 |
2002-01-10 |
Kyowa Hakko Kogyo Kk |
Heilmittel für thrombozytopenia
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5869445A
(en)
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
CA2167042A1
(en)
|
1993-07-15 |
1995-01-26 |
Kyle J. Lindstrom |
Imidazo[4,5-c]pyridin-4-amines
|
|
US5624949A
(en)
|
1993-12-07 |
1997-04-29 |
Eli Lilly And Company |
Protein kinase C inhibitors
|
|
ATE456367T1
(de)
|
1993-12-23 |
2010-02-15 |
Lilly Co Eli |
Proteinkinase c inhibitoren
|
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
DE69536015D1
(de)
|
1995-03-30 |
2009-12-10 |
Pfizer Prod Inc |
Chinazolinone Derivate
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
US5747498A
(en)
*
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5554519A
(en)
|
1995-08-07 |
1996-09-10 |
Fermalogic, Inc. |
Process of preparing genistein
|
|
AU6888196A
(en)
|
1995-08-11 |
1997-03-12 |
Yale University |
Glycosylated indolocarbazole synthesis
|
|
FR2741881B1
(fr)
|
1995-12-01 |
1999-07-30 |
Centre Nat Rech Scient |
Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
|
|
EE03484B1
(et)
|
1995-12-08 |
2001-08-15 |
Janssen Pharmaceutica N.V. |
Farnesüülproteiintransferaasi inhibeerivad (5-imidasolüül)metüül-2-kinolinooni derivaadid ja nende kasutamine
|
|
JP2000511769A
(ja)
|
1996-04-02 |
2000-09-12 |
スミスクライン・ビーチャム・コーポレイション |
新規化合物
|
|
US5849733A
(en)
|
1996-05-10 |
1998-12-15 |
Bristol-Myers Squibb Co. |
2-thio or 2-oxo flavopiridol analogs
|
|
EP0934336A1
(en)
|
1996-05-14 |
1999-08-11 |
Smithkline Beecham Corporation |
Novel compounds
|
|
KR100447918B1
(ko)
|
1996-07-25 |
2005-09-28 |
동아제약주식회사 |
대장을포함한위장관보호작용을갖는플라본및플라바논화합물
|
|
DE19630390A1
(de)
|
1996-07-26 |
1998-01-29 |
Chiron Behring Gmbh & Co |
Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung
|
|
CA2639051A1
(en)
|
1996-09-04 |
1998-03-12 |
Takara Bio Inc. |
Fungal antigens and process for producing the same
|
|
US5908934A
(en)
|
1996-09-26 |
1999-06-01 |
Bristol-Myers Squibb Company |
Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs
|
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
|
WO1998018931A2
(en)
|
1996-10-31 |
1998-05-07 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae polynucleotides and sequences
|
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
ATE432348T1
(de)
|
1997-06-06 |
2009-06-15 |
Univ California |
Inhibitoren von immunstimulatorischen dna sequenz aktivität
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
ES2253821T3
(es)
|
1997-07-12 |
2006-06-01 |
Cancer Research Technology Limited |
Derivados de purina inhibidores de quinasa que depende de ciclina.
|
|
US5948413A
(en)
|
1997-07-17 |
1999-09-07 |
Board Of Trustees Operating Michigan State University |
Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals
|
|
DE69838992T2
(de)
|
1997-09-05 |
2008-12-24 |
Glaxosmithkline Biologicals S.A., Rixensart |
Öl-in-Wasser Emulsionen mit Saponinen
|
|
BR9814878A
(pt)
|
1997-11-21 |
2000-10-03 |
Genset Sa |
Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
|
|
BR9814912A
(pt)
|
1997-11-28 |
2000-10-03 |
Genset Sa |
Sequência genÈmica e polipeptìdeos de chlamydia trachomatis, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
|
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
GB9807721D0
(en)
|
1998-04-08 |
1998-06-10 |
Chiron Spa |
Antigen
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
GB9810193D0
(en)
|
1998-05-12 |
1998-07-08 |
Smithkline Beecham Biolog |
Novel compounds
|
|
CA2314156C
(en)
|
1998-05-29 |
2010-05-25 |
Sugen, Inc. |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
|
WO2000018769A2
(en)
|
1998-09-30 |
2000-04-06 |
Wrair (Walter Reid Army Institute Of Research) |
INDOLO[2,1-b]QUINAZOLE-6,12-DIONE ANTIMALARIAL COMPOUNDS AND METHODS OF TREATING MALARIA THEREWITH
|
|
CN1338005A
(zh)
|
1998-10-09 |
2002-02-27 |
希龙公司 |
奈瑟球菌基因组序列及其用途
|
|
CZ301212B6
(cs)
|
1998-10-16 |
2009-12-09 |
Smithkline Beecham Biologicals S. A. |
Vakcinacní prostredek
|
|
US20030083242A1
(en)
|
1998-11-06 |
2003-05-01 |
Alphonse Galdes |
Methods and compositions for treating or preventing peripheral neuropathies
|
|
EP1133572A4
(en)
|
1998-11-12 |
2005-06-15 |
Univ California |
GENOMIC SEQUENCE OF CHLAMYDIA PNEUMONIAE
|
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
|
EP1162999B1
(en)
|
1999-03-19 |
2006-11-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
|
TR200103018T2
(tr)
|
1999-04-19 |
2002-02-21 |
Beecham Biologicals S.A. Smithkline |
İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
|
|
WO2000067161A2
(en)
|
1999-05-04 |
2000-11-09 |
Grant Lee H |
Method and apparatus for categorizing and retrieving network pages and sites
|
|
WO2001004125A1
(en)
|
1999-07-13 |
2001-01-18 |
Kyowa Hakko Kogyo Co., Ltd. |
Staurosporin derivatives
|
|
WO2001008636A2
(en)
|
1999-08-03 |
2001-02-08 |
The Ohio State University |
Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
|
|
JP2003509473A
(ja)
|
1999-09-24 |
2003-03-11 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
KR20020048942A
(ko)
|
1999-09-24 |
2002-06-24 |
장 스테판느 |
폴리옥시에틸렌 알킬 에테르 또는 에스테르 및 하나이상의 비이온성 계면활성제를 포함하는 애쥬번트
|
|
EE05330B1
(et)
*
|
1999-11-05 |
2010-08-16 |
Astrazeneca Ab |
Kinasoliini derivaadid kui VEGF-i inhibiitorid
|
|
EP2275129A3
(en)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
|
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US6573293B2
(en)
|
2000-02-15 |
2003-06-03 |
Sugen, Inc. |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
|
AU5342701A
(en)
|
2000-04-12 |
2001-10-30 |
Genaera Corp |
A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
|
|
AU7307101A
(en)
|
2000-06-30 |
2002-01-14 |
Glaxo Group Ltd |
Quinazoline ditosylate salt compounds
|
|
MXPA03001359A
(es)
*
|
2000-08-18 |
2004-12-13 |
Millennium Pharm Inc |
Derivados de quinazolina como inhibidores de cinasa.
|
|
AU8743001A
(en)
|
2000-08-28 |
2002-03-13 |
Aventis Pasteur |
Moraxella polypeptides and corresponding dna fragments and uses thereof
|
|
US6677450B2
(en)
|
2000-10-06 |
2004-01-13 |
Bristol-Myers Squibb Company |
Topoisomerase inhibitors
|
|
WO2002034771A2
(en)
|
2000-10-27 |
2002-05-02 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
|
WO2002062826A1
(fr)
|
2001-02-07 |
2002-08-15 |
Vadim Viktorovich Novikov |
Procede de fabrication des peptides
|
|
US7407664B2
(en)
|
2001-05-18 |
2008-08-05 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Peptide vaccines against group A streptococci
|
|
US20040186172A1
(en)
|
2001-07-02 |
2004-09-23 |
Houssam Ibrahim |
Oxaliplatin active substance with a very low content of oxalic acid
|
|
KR100484504B1
(ko)
|
2001-09-18 |
2005-04-20 |
학교법인 포항공과대학교 |
쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
|
|
US20030134846A1
(en)
|
2001-10-09 |
2003-07-17 |
Schering Corporation |
Treatment of trypanosoma brucei with farnesyl protein transferase inhibitors
|
|
GB0126879D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Astrazeneca Ab |
Combination therapy
|
|
AU2002316231A1
(en)
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
GB0210128D0
(en)
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
|
US6900342B2
(en)
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
|
US6727272B1
(en)
|
2002-07-15 |
2004-04-27 |
Unitech Pharmaceuticals, Inc. |
Leflunomide analogs for treating rheumatoid arthritis
|
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
ES2504166T3
(es)
|
2002-09-13 |
2014-10-08 |
Novartis Vaccines And Diagnostics, Inc. |
Vacuna de estreptococo del grupo B
|
|
AU2003264488A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Orient Cancer Therapy Co., Ltd. |
Immunotherapeutic for cancer
|
|
JP4896715B2
(ja)
|
2003-06-26 |
2012-03-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫原性組成物
|
|
EP1648500B1
(en)
|
2003-07-31 |
2014-07-09 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions for streptococcus pyogenes
|